Does IPILIMUMAB Cause Pulmonary toxicity? 131 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Pulmonary toxicity have been filed in association with IPILIMUMAB (YERVOY). This represents 0.4% of all adverse event reports for IPILIMUMAB.
131
Reports of Pulmonary toxicity with IPILIMUMAB
0.4%
of all IPILIMUMAB reports
21
Deaths
59
Hospitalizations
How Dangerous Is Pulmonary toxicity From IPILIMUMAB?
Of the 131 reports, 21 (16.0%) resulted in death, 59 (45.0%) required hospitalization, and 12 (9.2%) were considered life-threatening.
Is Pulmonary toxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 131 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Pulmonary toxicity?
AMIODARONE (886)
METHOTREXATE (811)
HYDROXYCHLOROQUINE (411)
RITUXIMAB (404)
TOCILIZUMAB (395)
LEFLUNOMIDE (364)
ABATACEPT (359)
ADALIMUMAB (326)
PEMBROLIZUMAB (318)
ETANERCEPT (291)
Which IPILIMUMAB Alternatives Have Lower Pulmonary toxicity Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN